Nicholas Investment Partners’s BioTelemetry, Inc. BEAT Stock Holding History

Nicholas Investment Partners’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-61,786	Closed	-$3.87M	–	249
2019 Q1	$3.87M	Buy	61,786 +1,739	+3%	+$119K	0.35%	98
2018 Q4	$3.59M	Sell	60,047 -568	-0.9%	-$34.1K	0.39%	93
2018 Q3	$3.91M	Buy	+60,615	New	+$3.38M	0.31%	125
2017 Q4	–	Sell	-178,968	Closed	-$5.91M	–	287
2017 Q3	$5.91M	Buy	178,968 +64,994	+57%	+$2.25M	0.41%	66
2017 Q2	$3.81M	Sell	113,974 -43	-0%	-$1.28K	0.27%	126
2017 Q1	$3.3M	Sell	114,017 -22,907	-17%	-$567K	0.23%	158
2016 Q4	$3.06M	Buy	+136,924	New	+$2.68M	0.23%	181

Other funds holding BEAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Nicholas Investment Partners's BEAT Position: Q2 2019 in Review

Nicholas Investment Partners sold out of BioTelemetry, Inc. (BEAT) in Q2 2019, closing a stake of 61,786 shares — an estimated $3.87M sold.

Nicholas Investment Partners first reported a position in BEAT in Q4 2016 and held it in 7 quarters. The position peaked at $5.91M in Q3 2017. 251 funds tracked by Wall St. Rank hold BEAT as of Q2 2019.

Nicholas Investment Partners reported no remaining BioTelemetry, Inc. position as of Q2 2019 after selling out during the quarter.
Nicholas Investment Partners sold 61,786 BioTelemetry, Inc. shares in Q2 2019, an estimated $3.87M.
Nicholas Investment Partners first reported a position in BioTelemetry, Inc. in Q4 2016 and held it in 7 quarters.
Nicholas Investment Partners's BioTelemetry, Inc. position peaked at $5.91M in Q3 2017.
251 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q2 2019.

Based on Nicholas Investment Partners's 13F filing for Q2 2019, filed 9 Aug 2019.